In the Fra-2 transgenic mice model, the pulmonary vasculature remodeling was attenuated by blocking MMP-10 and there is increased expression of stromelysin 2 (MMP-10) in pulmonary vasculature and serum among subjects with SSc [71]. Here, MMP10 is linked to systemic sclerosis.